Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Positive phase 2b data show duvakitug met primary endpoints for clinical remission in ulcerative colitis and endoscopic response in Crohn disease.

Duvakitug Meets Primary Endpoints in Phase 2b RELIEVE UCCD Study for IBD

The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.

J&J Submits sBLA for Guselkumab (Tremfya) Subcutaneous Induction Regimen in UC

HCPLive spoke with Kastl at NASPGHAN about the team’s study on the immune response to the COVID-19 vaccination among children with IBD.

Children with IBD Respond Well to the Pfizer COVID-19 Vaccination, with Arthur Kastl, MD

At NASPGHAN, HCPLive spoke to Hamant about her team’s study that showed their algorithm was linked to increased VTE Prophylaxis among Pediatric IBD.

Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children

At NASPGHAN 2024, Collen told HCPLive the promising early data of advanced combination therapy for pediatric refractory IBD although hurdles exist.

Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD

HCPLive spoke to Collen at NASPGHAN 2024 about early research on environmental exposures prevalent in children with Crohn’s Disease.


Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes  of Children with Crohn’s Disease

At NASPGHAN 2024, HCPLive spoke to Shameem about his study on inpatient outcomes of pediatric patients with IBD and GAD vs patients without GAD.

Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD

A retrospective review of a community-based practice provides insights into navigating setbacks in IBD care initiation due to insurance requirements.

Prior Authorization Managers, Care Management Homes Could Expedite IBD Care

Sands reviews long-term phase 3 data from the LUCENT-3 and VIVID-2 extension studies of mirikizumab in UC and CD presented at ACG 2024.

Bruce Sands, MD: Long-Term Data for Mirikizumab in Ulcerative Colitis, Crohn’s Disease

Axelrad reviews preliminary findings from a study assessing the utility of a new monitoring technology for improving IBD medication adherence and outcomes.

Jordan Axelrad, MD, MPH: Addressing Nonadherence to IBD Therapies with Remote Monitoring

On the HCPLive inflammatory bowel disease page, resources on the topics of medical news and expert insight into IBD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBD and more.

Inflammatory Bowel Disease